Showing results (71-80 of 6,996) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Lung Cancer (Amsterdam, Netherlands)|February 2, 2025
Evaluating lung cancer risk factors in adults with interstitial lung diseaseJane Dobkin, B Payne Stanifer, Mary Salvatore, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Survival benefit and potential markers of chemotherapy for elderly and poor performance status patients with advanced non-small cell lung cancer: Results from the Japanese Joint Committee of lung cancer registry databaseSatoshi Ikeda, Takashi Ogura, Etsuo Miyaoka, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2025
Dual onsets of small cell lung cancer with contrasting neuroendocrine features and immune microenvironments: A case reportToshiyuki Sumi, Taiki Ishigooka, Keigo Matsuura, et al.
Lung Cancer (Amsterdam, Netherlands)|February 2, 2025
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trialKi Hyeong Lee, Jong-Seok Lee, Shunichi Sugawara, et al.
Lung Cancer (Amsterdam, Netherlands)|January 29, 2025
Artificial intelligence for diagnosis and predictive biomarkers in Non-Small cell lung cancer Patients: New promises but also new hurdles for the pathologistPaul Hofman, Iordanis Ourailidis, Eva Romanovsky, et al.
Lung Cancer (Amsterdam, Netherlands)|January 29, 2025
Adherence to community-based lung cancer screening in the Yorkshire Lung Screening TrialSarah Q Ahmad, Francesca Pesola, Philip A J Crosbie, et al.
Lung Cancer (Amsterdam, Netherlands)|January 31, 2025
Diagnostic and prognostic relevance of inflammatory markers in surgically treated thymic epithelial tumors: An international multicenter studyEvelyn Megyesfalvi, Aron Ghimessy, Jonas Bauer, et al.
Lung Cancer (Amsterdam, Netherlands)|January 31, 2025
Comparative analysis of first-line treatment in NSCLC including unresectable stage III (IIIB/IIIC) and stage IV with low PD-L1 expression: Clinical trial eligible versus ineligible patientsTae Hata, Tadaaki Yamada, Yasuhiro Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2025
Identification of key gene signatures for predicting chemo-immunotherapy efficacy in extensive-stage small-cell lung cancer using machine learningDaichi Fujimoto, Ryota Shibaki, Keiichi Kimura, et al.
Pageof 700